Potential cost-effectiveness of community availability of tenofovir, lamivudine, and dolutegravir for HIV prevention and treatment in east, central, southern, and west Africa: a modelling analysis.

Journal: The Lancet. Global health

Publication Year: 2023

Authors & Co-authors:  Phillips Andrew N AN Bansi-Matharu Loveleen L Shahmanesh Maryam M Hargreaves James R JR Smith Jennifer J Revill Paul P Sibanda Euphemia E Ehrenkranz Peter P Sikwese Kenly K Rodger Alison A